Insulin dependent diabetes mellitus (IDDM) is caused by a paucity of insulin-producing cells in the islets of Langerhans. In virtually all circumstances the islet cells have no regenerative capacity after birth and once they are destroyed by inflammatory cells no recovery is possible. In this proposal we will study the mechanism by which the insulin-producing beta cells are regenerated with the eventual goal of identifying specific factors that are critically involved in their development. For these studies we will utilize a strain of transgenic mice that has demonstrated a dramatically high level of pancreatic duct cell proliferation and neogenesis of islet cells during adult life. The experimental studies proposed in this application will distinguish between two potential models accounting for the observed regeneration. We will determine what potentially inductive molecules are present in the regenerating pancreas. The identity of cells required for the proliferation/differentiation will be established by perturbing the system genetically and through the use of mechanisms that allow the depletion of specific cell categories in the regenerating pancreas. Lastly, we will utilize an in vitro system to integrate the data collected from the studies on the transgenic mice. Cultures of pancreatic duct epithelial cells will be derived from both transgenic and non-transgenic animals. These duct cells cultures will be studied histologically and also for their ability to differentiate in vitro and in vivo. Lastly, we will design specific strategies, based upon the information gained in the proposed studies to induce islet cell differentiation in vitro. The proposed studies will augment the potential of inducing islet cell growth and regrowth as a means of replenishing the insulin producing machinery lost in IDDM.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
1R01HD029764-01
Application #
3331252
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Project Start
1993-01-01
Project End
1995-12-31
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Flodstrom, M; Horwitz, M S; Maday, A et al. (2001) A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection. Virology 281:205-15
Krakowski, M; Yeung, B; Abdelmalik, R et al. (2000) IFN-gamma overexpression within the pancreas is not sufficient to rescue Pax4, Pax6, and Pdx-1 mutant mice from death. Pancreas 21:399-406
Kritzik, M R; Krahl, T; Good, A et al. (2000) Expression of ErbB receptors during pancreatic islet development and regrowth. J Endocrinol 165:67-77
Davies, J D; Mueller, R; Minson, S et al. (1999) Interleukin-4 secretion by the allograft fails to affect the allograft-specific interleukin-4 response in vitro. Transplantation 67:1583-9
Bradley, L M; Asensio, V C; Schioetz, L K et al. (1999) Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J Immunol 162:2511-20
Davies, J D; O'Connor, E; Hall, D et al. (1999) CD4+ CD45RB low-density cells from untreated mice prevent acute allograft rejection. J Immunol 163:5353-7
Balasa, B; Lee, J; Sarvetnick, N (1999) Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice. Cell Immunol 193:170-8
Krakowski, M L; Kritzik, M R; Jones, E M et al. (1999) Pancreatic expression of keratinocyte growth factor leads to differentiation of islet hepatocytes and proliferation of duct cells. Am J Pathol 154:683-91
Mueller, R; Krahl, T; Sarvetnick, N (1997) Tissue-specific expression of interleukin-4 induces extracellular matrix accumulation and extravasation of B cells. Lab Invest 76:117-28
Gu, D; Arnush, M; Sarvetnick, N (1997) Endocrine/exocrine intermediate cells in streptozotocin-treated Ins-IFN-gamma transgenic mice. Pancreas 15:246-50

Showing the most recent 10 out of 33 publications